Hosted on MSN

FBLG: Poster Presentation Shows Potential for Fibroblast Therapy in Psoriasis…

On May 16, 2025, FibroBiologics, Inc. (NASDAQ:FBLG) announced a poster presentation at the Society for Investigative Dermatology (SID) Annual Meeting. The poster entitled “Immunomodulatory Potential ...
Nasdaq

FibroBiologics Announces Presentation on Innovative Fibroblast-Based Therapeutics at The German-Nordic Joint Extracellular Matrix Meeting

FibroBiologics will present on fibroblast-based therapies for chronic diseases at a conference in Freiburg, Germany, on March 27, 2025. FibroBiologics, Inc., a biotechnology company focused on ...

FibroBiologics, Inc. (FBLG) Discusses Strategy and Clinical Progress in Fibroblast-Based Cell Therapies for Chronic Diseases Transcript

Discusses Strategy and Clinical Progress in Fibroblast-Based Cell Therapies for Chronic Diseases September 22, 2026 4:15 ...
Stanford Daily

Dissecting the role of innate immune signaling in fibroblasts in wound healing

Holman Day is Stanford Surgery's annual celebration of science. The Holman Lecture Series and Research Day commemorates the life and accomplishments of Founding Department Chair Emile Frederic Holman, ...
Morningstar%2c Inc.

FibroBiologics Granted U.S. Patent Covering the Use of Fibroblasts to Enhance Survival and Function of Transplanted Insulin-Producing Islets

Patent has potential for applications beyond diabetes, including other cell and tissue transplantation procedures HOUSTON, Aug. 11, 2026 /PRNewswire/ -- FibroBiologics, Inc. (Nasdaq: FBLG) ...